These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6310295)

  • 1. Testosterone does not influence opiate binding sites in the male rat brain.
    Cicero TJ; Newman KS; Meyer ER
    Life Sci; 1983 Sep; 33(13):1231-9. PubMed ID: 6310295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further evidence that gonadal steroids do not modulate brain opiate receptors in male rats.
    Olasmaa M; Limonta P; Maggi R; Dondi D; Martini L; Piva F
    Endocrinol Jpn; 1987 Aug; 34(4):521-9. PubMed ID: 2824184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone-induced opiate receptor supersensitivity.
    Zukin RS; Sugarman JR; Fitz-Syage ML; Gardner EL; Zukin SR; Gintzler AR
    Brain Res; 1982 Aug; 245(2):285-92. PubMed ID: 6289965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in rat brain opiate receptor content upon castration and testosterone replacement.
    Hahn EF; Fishman J
    Biochem Biophys Res Commun; 1979 Oct; 90(3):819-23. PubMed ID: 228671
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex.
    Rothman RB; Bykov V; Mahboubi A; Long JB; Jiang Q; Porreca F; de Costa BR; Jacobson AE; Rice KC; Holaday JW
    Synapse; 1991 Jun; 8(2):86-99. PubMed ID: 1652797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the affinity ligands 14-beta-chloroacetylnaltrexone and 14-beta-bromoacetamidomorphine on [3H]-dihydromorphine binding sites in rat brain.
    Reichman M; Dirksen R; Abood LG; Gala D
    Biochem Pharmacol; 1986 Nov; 35(22):3995-8. PubMed ID: 3022745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding to rat brain homogenates of Mr2034, a universal opiate.
    Johnson N; Pasternak GW
    Life Sci; 1983 Sep; 33(10):985-91. PubMed ID: 6310291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL; Recht LD; Pasternak GW
    Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualization of mu1 opiate receptors in rat brain by using a computerized autoradiographic subtraction technique.
    Goodman RR; Pasternak GW
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6667-71. PubMed ID: 2995978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of a new opiate antagonist, nalmefene, to rat brain membranes.
    Michel ME; Bolger G; Weissman BA
    Methods Find Exp Clin Pharmacol; 1985 Apr; 7(4):175-7. PubMed ID: 2991678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T; Zukin RS
    Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid-specific recognition sites of the mu- and the delta-type in rat striatum after lesions with kainic acid.
    Antkiewicz-Michaluk L; Havemann U; Vetulani J; Wellstein A; Kuschinsky K
    Life Sci; 1984 Jul; 35(4):347-55. PubMed ID: 6087059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
    Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A
    Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic ethanol changes opiate receptor function in rat striatum.
    Lucchi L; Rius RA; Uzumaki H; Govoni S; Trabucchi M
    Brain Res; 1984 Feb; 293(2):368-71. PubMed ID: 6320974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of mu opioid receptors in the brain and in the hypothalamus of the aged male rat.
    Piva F; Maggi R; Limonta P; Dondi D; Martini L
    Life Sci; 1987 Jan; 40(4):391-8. PubMed ID: 3027483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective proliferation of brain kappa opiate receptors in spontaneously hypertensive rats.
    Bhargava HN; Das S
    Life Sci; 1986 Dec; 39(26):2593-600. PubMed ID: 3025539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the binding characteristics of hypothalamic mu opioid receptors in rats by gonadal steroids.
    Maggi R; Limonta P; Dondi D; Piva F
    J Steroid Biochem Mol Biol; 1991; 40(1-3):113-21. PubMed ID: 1659872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opiate and opioid peptide binding in rat goldfish: further evidence for opiate receptor heterogeneity.
    Nishimura S; Pasternak GW
    Brain Res; 1982 Sep; 248(1):192-5. PubMed ID: 6289993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites.
    Rothman RB; Bykov V; Long JB; Brady LS; Jacobson AE; Rice KC; Holaday JW
    Eur J Pharmacol; 1989 Jan; 160(1):71-82. PubMed ID: 2540993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.